History and mission

TEDD ( Tissue Engineering for Drug Developemnt and Substance Testing) was established together with the introduction of 3D cell cultures technologies to the wider audience. The center aims at fostering 3D cell culture approaches for drug development, personalized, regenerative medicine and basic science, contributing actively to key technology development and translating in vitro assays into predictive tests of clinical and pharmaceutical relevance. In order to maximize the success, cooperation of partners with complementary skills – academia, industry (in particular biotechnology, pharmaceutical, medtech and cosmetics companies) and clinics is required. TEDD community strengthen the research and business location of Switzerland and Europe by responding to key medical, pharmaceutical and societal demands. By routine application of 3D tissue models, the 3Rs initiative will be implemented by reducing, refining and replacing animal experimentation.

 

More details…

Website Link…

 

Recent Posts

Focus on: anti-pollution beauty via Cosmetics Design

Kirsty Doolan 12 February 2025 We examine what's new in tropical and ingestible beauty products…

Consumer feedback integrated in real time into fragrance creation via Industries Cosmétiques

10 February 2025 IFF announces the launch of its new artificial intelligence (AI)-powered search tool:…

Brazil: imports of Chinese cosmetics surged by 47% last year via Premium Beauty News

Renata Martins 6 February 2025 The global cosmetics market is evolving rapidly with an influx…